Tagrisso (osimertinib) from AstraZeneca has been given the approval in the US to treat adult patients with unresectable, Stage III EGFRm NSCLC who have not seen their disease worsen after platinum-based CRT. Tagrisso is approved for individuals...
The World Health Organization (WHO) issued guidance on how to enhance the organization and supervision of clinical trials in nations with diverse income levels. This guidance seeks to enhance country-led R&D ecosystems in order to progress health...
Sklepios BioPharmaceutical (AskBio), has formed a strategic alliance with Belief BioMed in China to further the progress of innovative gene therapies. The goal of the collaboration is to take advantage of the experience of both companies in gene...
MediBuddy, the biggest digital healthcare platform in India, has partnered with Philips, a global leader in health technology, to transform preventive healthcare in India. For World Heart Day on September 29, the collaboration will provide heart...
MedGenome, a prominent worldwide genomics-focused diagnostics and research services company, is joining forces with Twist Bioscience, a fast-growing synthetic biology and genomics company in the US, to create the HOPE for Rare Diseases Programme...
PreAnalytiX GmbH, formed by QIAGEN N.V. and BD, has introduced the PAXgene Urine Liquid Biopsy Set for analyzing cell-free DNA in urine using various molecular testing technologies like qPCR, digital PCR, and NGS. QIAGEN will commercialize the new...
Takeda has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) to produce and sell Fruzaqla capsules 1mg/5mg (fruquintinib), an oral inhibitor of VEGFR-1, -2, and -3, for advanced or recurring colorectal cancer treatment...
AIIMS New Delhi and Intuitive, a global leader in minimally invasive technology and robotic-assisted surgery, signed an MoU to create a new training center for robotic-assisted surgery at AIIMS, New Delhi. The AIIMS da Vinci RAS training centre...
PCI Pharma Services, a top CDMO specializing in complex biopharma therapies, is dedicating over $365 million to enhance infrastructure for assembling and packaging drug-device combination products with advanced drug delivery systems, particularly...
Innate Pharma SA, a worldwide biotech firm in clinical stages advancing cancer immunotherapies, reported that the FDA has approved its IND application for a phase 1 clinical trial of IPH4502, a unique topoisomerase I inhibitor ADC targeting...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
